P-087 A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancer

Por Yoshino, S., Nishimura, T., Sakata, K., Yoshida, S., Furuya, T., Yamamoto, T., Kawaoka, T., Shimizu, R., Sato, T., Matoba, K., Morioka, H., Iida, M., Suzuki, N., Takeda, S., Ueno, T., Hazama, S., Nagano, H.
Publicado no Ann Oncol (2016)